Recent Posts
Connect with:
Wednesday / May 25.
HomeminewsRapid Ophthal Growth

Rapid Ophthal Growth

An ageing population that has created a large pool of patients with eye diseases, changing demographics and an increased focus on combination therapies of pharmaceuticals is boosting the global ophthalmology pharmaceutical and devices market, which is now expected to grow to USD$52.4 billion by 2017.[/vc_column_text][/vc_column]

According to MarketsandMarkets, much of the predicted growth is expected to occur in the Asia Pacific region led by demand from India and China. The company says more mature markets, such as Europe and North America, will grow at a slower pace as a result of economic difficulties.

Additionally, the pharmaceuticals market is expected to grow at a slower pace compared with the devices market. That’s because of the patent cliff and a less-than-robust pipeline of future products.

Meanwhile according to the latest research, the eyewear sector is facing a different scenario. Market Watch in the United States has identified an increase in the sale of optical products (frames, lenses and contact lenses) of 3.4 per cent from 2010– 11. In Australia, the annual Eye Talk Survey highlighted reduced revenue from optometry practices of around 4 per cent.

See mivision’s lead news story on this page for more information on the optical market.


By agreeing & continuing, you are declaring that you are a registered Healthcare professional with an appropriate registration. In order to view some areas of this website you will need to register and login.
If you are not a Healthcare professional do not continue.